Low prevalence of antiretroviral drug resistance mutations in drug naive patients with established HIV infection in the UK

被引：0
|
作者：
Burke, A [1 ]
Thorne, N [1 ]
Loveday, C [1 ]
机构：
[1] UCL Royal Free & Univ Coll, Sch Med, Retrovirol Dept, London NW3 2PF, England
来源：
AIDS | 2000年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P362
引用
收藏
页码：S121 / S122
页数：2
相关论文
共 50 条
  • [41] Prevalence of antiretroviral drug resistance and resistance-associated mutations in antiretroviral therapy-naive HIV-infected individuals from 40 United States cities
    Ross, Lisa
    Lim, Michael L.
    Liao, Qiming
    Wine, Brian
    Rodriguez, Allan E.
    Weinberg, Winkler
    Shaefer, Mark
    [J]. HIV CLINICAL TRIALS, 2007, 8 (01): : 1 - 8
  • [42] Prevalence of HIV type 1 drug resistance mutations in treatment-naive patients participating in the GARDEL study
    Ines Figueroa, Maria
    Patterson, Patricia
    Cahn, Pedro
    Andrade-Villanueva, Jaime
    Arribas, Jose
    Gatell, Jose
    Lama, Javier
    Norton, Michael
    Sierra Madero, Juan
    Sued, Omar
    Jose Rolon, Maria
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [43] Drug-selected resistance mutations and non-B subtypes in antiretroviral-naive adults with established human immunodeficiency virus infection
    Hanna, GJ
    Balaguera, HU
    Freedberg, KA
    Werner, BG
    Craven, KAS
    Craven, DE
    D'Aquila, RT
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (07): : 986 - 991
  • [44] Prevalence and Significance of HIV-1 Drug Resistance Mutations among Patients on Antiretroviral Therapy with Detectable Low-Level Viremia
    Li, Jonathan Z.
    Gallien, Sebastien
    Do, Tri D.
    Martin, Jeffrey N.
    Deeks, Steven
    Kuritzkes, Daniel R.
    Hatano, Hiroyu
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (11) : 5998 - 6000
  • [45] Investigation of HIV-1 Primary Drug Resistance Mutations in Antiretroviral Therapy-Naive Cases
    Yalcinkaya, Tulay
    Kose, Sukran
    [J]. MIKROBIYOLOJI BULTENI, 2014, 48 (04): : 585 - 595
  • [46] Drug-selective pressure effect on HIV integrase mutations in antiretroviral naive and experienced patients
    Basimi, Parya
    Farrokhi, Molood
    Ghanbari, Maryam
    Manshadi, Seyed Ali Dehghan
    Naghib, Maryam
    Baesi, Kazem
    [J]. HIV & AIDS REVIEW, 2023, 22 (02): : 99 - 103
  • [47] Prevalence and predictors of antiretroviral drug resistance in newly diagnosed HIV-1 infection
    Booth, Clare L.
    Garcia-Diaz, Ana M.
    Youle, Michael S.
    Johnson, Margaret A.
    Phillips, Andrew
    Geretti, Anna Maria
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (03) : 517 - 524
  • [48] Prevalence and Clinical Significance of HIV Drug Resistance Mutations by Ultra-Deep Sequencing in Antiretroviral-Naive Subjects in the CASTLE Study
    Lataillade, Max
    Chiarella, Jennifer
    Yang, Rong
    Schnittman, Steven
    Wirtz, Victoria
    Uy, Jonathan
    Seekins, Daniel
    Krystal, Mark
    Mancini, Marco
    McGrath, Donnie
    Simen, Birgitte
    Egholm, Michael
    Kozal, Michael
    [J]. PLOS ONE, 2010, 5 (06):
  • [49] Prevalence of antiretroviral drug genotypic resistance among HIV patients in Cuenca, Spain
    Rodriguez-Escudero, M. J.
    de Medio, E. Prada
    Herranz, C. Rosa
    Medina, M. C. Martinez
    Gutierrez, R. Franquelo
    [J]. REVISTA ESPANOLA DE QUIMIOTERAPIA, 2007, 20 (02) : 203 - 205
  • [50] High prevalence of multiple drug resistance mutations in a UK HIV/AIDS patient population
    Loveday, C
    Devereux, H
    Huckett, L
    Johnson, M
    [J]. AIDS, 1999, 13 (05) : 627 - 628
12345